Feb. 8, 2011 (Baystreet.ca) --
Palm Beach, FL--- Today FreeBiotechStockAlert.com announces four stocks to watch closely: Neurokine Pharmaceuticals (OTCBB:NEUKF), Bionovo Inc. (BNVI), Corcept Therapeutics (CORT), and Inhibitex, Inc. (INHX).
Biotech Stocks to watch:
Neurokine Pharmaceuticals (OTCBB:NEUKF)The Company announced that it has signed a contract with Clinical Investigations Group (CIG) of U.K. to conduct Phase II human clinical trials to study the effects of NK-001 in protecting patients against cognitive impairment (Alzheimer's-type) side effects of coronary artery bypass graft (CABG) surgery. CIG will conduct these trials in 50 patients at 3 clinical investigation centers in Europe. These sites have been previously approved by CGI to have outstanding expertise in cardio-surgery and psychiatry. The Company will immediately begin to collaborate with CGI to complete all necessary documentation for submission of approval of its protocol for human clinical trials in Europe.
Neurokine Pharmaceuticals Inc. focuses on development of new use for existing marketed products for diseases mediated by acute and chronic inflammatory reactions. The Company is developing proprietary encapsulation technology to allow better blood brain barrier penetration to initiate or enhance therapeutic effects of anti-inflammatory drugs in the treatment of neurodegenerative diseases.
Bionovo Inc. (BNVI)Bionovo, Inc. is a development stage company engaged in the development of pharmaceuticals, derived from botanical sources, to treat cancer and women’s health.
Corcept Therapeutics (CORT) Corcept is a pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders.
Inhibitex, Inc. (INHX) The Company's research and development efforts are currently focused on small molecule antiviral compounds, and in particular, orally-available therapies to treat herpes zoster, also referred to as shingles, and chronic infections caused by HCV.
At www.FreeBiotechStockAlert.com we know that nothing speaks louder than our picks and the success of our subscribers! In today's markets, investors need to be in the know. Knowledge is more than power, its money. That's why our team at FreeBiotechStockAlert.com tracks the hottest stocks all over the biotech market in order to keep our subscribers tuned in. We focus mainly on microcap, small cap and penny stock companies - companies that allow our investors to bring home big profits. We work diligently and provide all investors - large or small - an opportunity to track stocks with the potential to make big gains.
Join our FREE newsletter at FreeBiotechStockAlert.com and receive our report coming out next week.
While many of the other investment newsletters talk a big game, at FreeBiotechStockAlert.com we let our research do the talking! We invite you to give us a try and sign up for free today at http://www.FreeBiotechStockAlert.com.
Disclaimer: FreeBiotechStockAlert.com is not a registered investment advisor. Investors are responsible for doing their own research and obtaining professional investment advice. FreeBiotechStockAlert.com does not guarantee the accurateness of information in its communications. Investors should read the full disclaimer at www.FreeBiotechStockAlert.com before investing in any stock featured by the site. FreeBiotechStockAlert.com is a division of Cooperman Bros.
For more information, please contact
FreeBiotechStockAlert.com Editor (888) 790-9777 info@FreeBiotechStockAlert.com